F. Barry Bays, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 36,962 shares at $23.24 ($852K) on 2022-12-20, disclosed to the SEC on 2022-12-21.
Open-market sale of $852k TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.86 | 9,067 | $207K | 24.3% |
| 2 | $22.86 | 9,067 | $207K | 24.3% |
| 3 | $23.24 | 9,414 | $219K | 25.7% |
| 4 | $23.24 | 9,414 | $219K | 25.7% |
| Total | $23.05 avg | 36,962 | $852K | 100% |
| Filing → |
| TMCI | SELL | 2023-04-13 | $4.5M | — | Filing → |
| TMCI | SELL | 2023-03-30 | $3.0M | — | Filing → |
| TMCI | SELL | 2023-03-15 | $646K | — | Filing → |